Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP832485.RAvDwV1N-A5g2PsHNUCnTPH_4g8oOKSC2otPTjAMkql-E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP832485.RAvDwV1N-A5g2PsHNUCnTPH_4g8oOKSC2otPTjAMkql-E130_assertion type Assertion NP832485.RAvDwV1N-A5g2PsHNUCnTPH_4g8oOKSC2otPTjAMkql-E130_head.
- NP832485.RAvDwV1N-A5g2PsHNUCnTPH_4g8oOKSC2otPTjAMkql-E130_assertion description "[Moreover, we suggest that the poor prognosis of breast cancer patients with high expression of CD47 is due to an active CD47/SIRPA signaling pathway in circulating cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP832485.RAvDwV1N-A5g2PsHNUCnTPH_4g8oOKSC2otPTjAMkql-E130_provenance.
- NP832485.RAvDwV1N-A5g2PsHNUCnTPH_4g8oOKSC2otPTjAMkql-E130_assertion evidence source_evidence_literature NP832485.RAvDwV1N-A5g2PsHNUCnTPH_4g8oOKSC2otPTjAMkql-E130_provenance.
- NP832485.RAvDwV1N-A5g2PsHNUCnTPH_4g8oOKSC2otPTjAMkql-E130_assertion SIO_000772 20705613 NP832485.RAvDwV1N-A5g2PsHNUCnTPH_4g8oOKSC2otPTjAMkql-E130_provenance.
- NP832485.RAvDwV1N-A5g2PsHNUCnTPH_4g8oOKSC2otPTjAMkql-E130_assertion wasDerivedFrom befree-2016 NP832485.RAvDwV1N-A5g2PsHNUCnTPH_4g8oOKSC2otPTjAMkql-E130_provenance.
- NP832485.RAvDwV1N-A5g2PsHNUCnTPH_4g8oOKSC2otPTjAMkql-E130_assertion wasGeneratedBy ECO_0000203 NP832485.RAvDwV1N-A5g2PsHNUCnTPH_4g8oOKSC2otPTjAMkql-E130_provenance.